Novel 3-(4-oxo-4h-chromen-2-yl)-(1H)-quinolin-4-one derivatives, method for preparing same and pharmaceutical compositions containing same
申请人:Brion Jean-Daniel
公开号:US20060063801A1
公开(公告)日:2006-03-23
Compound of formula (I):
wherein:
R
1
, R
2
, R
3
, R
4
, R
6
, R
8
, R
9
and R
10
, which may be the same or different, each represent a group selected from hydrogen, hydroxy, alkoxy, alkyl, arylalkoxy, alkoxycarbonylalkoxy and OR′ wherein R′ represents an ionised or ionisable group,
R
5
represents a group selected from alkyl, aryl and heteroaryl,
R
7
represents a group selected from hydrogen, hydroxy, alkoxy, alkyl and cycloalkyl, or R
7
represents a nitrogen-containing or oxygen-containing heterocycle, its optical isomers, hydrates and solvates thereof and addition salts thereof, with a pharmaceutically acceptable acid or base. Medicinal products containing the same which are useful as anti-cancer agents.
化合物的化学式(I)如下:其中:R1、R2、R3、R4、R6、R8、R9和R10,可能相同也可能不同,每个代表从氢、羟基、烷氧基、烷基、芳基烷氧基、烷氧羰基烷氧基和OR′中选择的一个基团,其中R′代表一个被电离或可电离的基团,R5代表从烷基、芳基和杂环烷基中选择的一个基团,R7代表从氢、羟基、烷氧基、烷基和环烷基中选择的一个基团,或者R7代表含氮或含氧的杂环,其光学异构体、水合物和溶剂合物以及与药用酸或碱形成的加合物。包含这些化合物的药物产品可用作抗癌剂。